Cutaneous clinical trials

Explore recruiting cutaneous clinical trials.

Recruiting cutaneous studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cutaneous trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled study to assess the effects of high concentration capsaicin patch (Qutenza) on neuropathic symptoms, nerve fibers, and microcirculation in painful diabetic peripheral neuropathy

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

The effect of anifrolumab on cutaneous lupus erythematosus characterized by the change of the inflammatory infiltrate analyzed by immunohistochemistry, spatial transcriptomics and single-cell RNA- and TCR-sequencing as well as on the clinical outcome - an open label, single arm phase IV pilot study

Austria

Therapeutic use (Phase IV) EU CTIS Study details

C0251013 - A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE CLINICAL EFFECT, PHARMACODYNAMIC, PHARMACOKINETIC AND SAFETY PROFILE OF PF-06823859 IN ADULT PARTICIPANTS WITH ACTIVE CLE OR SLE WITH CUTANEOUS MANIFESTATIONS

Spain, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

An interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial evaluating the efficacy and safety of Qutenza® in subjects with post-surgical neuropathic pain

Netherlands, Spain, Poland, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase III, multicentre, randomised, observer-blind, intraindividual, paired, comparative trial to evaluate the efficacy and safety of a 0.1% mometasone furoate cutaneous emulsion compared to Ecural® fat cream and vehicle cutaneous emulsion in the treatment of adult participants with plaque psoriasis

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

The effect of suprainguinal fascia iliaca compartment block A healthy volunteer trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Cutaneous trials by city

Cutaneous in Toronto Cutaneous in Vancouver Cutaneous in Montreal Cutaneous in Calgary Cutaneous in Edmonton Cutaneous in Ottawa Cutaneous in Winnipeg Cutaneous in Quebec City Cutaneous in Hamilton Cutaneous in Kitchener Cutaneous in London Cutaneous in Halifax Cutaneous in New York Cutaneous in Los Angeles Cutaneous in Chicago Cutaneous in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease